<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fermenta Biotech Limited has submitted a regulatory disclosure to BSE confirming that it does not qualify as a 'Large Corporate' under SEBI's framework. The company reported total outstanding borrowings of Rs. 17.39 crore as on March 31, 2026, well below the Large Corporate threshold. Its highest credit rating during the previous financial year was CARE BBB; Stable, assigned by CARE Ratings Limited. The Annexure B2 (Annual Disclosure) fields are all marked as 'Not Applicable' since the company is not classified as a Large Corporate. The filing was signed by the Company Secretary and CFO on April 28, 2026.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms the company's smaller borrowing base and that no mandatory debt-market borrowing requirements or penalties apply to Fermenta Biotech.